276 related articles for article (PubMed ID: 15802001)
1. Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention?
Wierzbicki AS
Curr Med Res Opin; 2005 Feb; 21(2):299-306. PubMed ID: 15802001
[TBL] [Abstract][Full Text] [Related]
2. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
3. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
[TBL] [Abstract][Full Text] [Related]
4. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein metabolism: potential therapeutic targets.
Davidson MH; Toth PP
Am J Cardiol; 2007 Dec; 100(11 A):n32-40. PubMed ID: 18047851
[TBL] [Abstract][Full Text] [Related]
6. Nicotinic acid and other therapies for raising high-density lipoprotein.
Carlson LA
Curr Opin Cardiol; 2006 Jul; 21(4):336-44. PubMed ID: 16755203
[TBL] [Abstract][Full Text] [Related]
7. Evidence to support aggressive management of high-density lipoprotein cholesterol: implications of recent imaging trials.
Taylor AJ
Am J Cardiol; 2008 Apr; 101(8A):36B-43B. PubMed ID: 18375240
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic acid and the prevention of coronary artery disease.
Digby JE; Lee JM; Choudhury RP
Curr Opin Lipidol; 2009 Aug; 20(4):321-6. PubMed ID: 19494772
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials.
Birjmohun RS; Hutten BA; Kastelein JJ; Stroes ES
J Am Coll Cardiol; 2005 Jan; 45(2):185-97. PubMed ID: 15653014
[TBL] [Abstract][Full Text] [Related]
10. Low HDL-C: a secondary target of dyslipidemia therapy.
Rosenson RS
Am J Med; 2005 Oct; 118(10):1067-77. PubMed ID: 16194634
[TBL] [Abstract][Full Text] [Related]
11. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
[TBL] [Abstract][Full Text] [Related]
12. The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'.
Devroey D; Velkeniers B; Duquet W; Betz W
Int J Cardiol; 2005 May; 101(2):231-5. PubMed ID: 15882669
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective.
Roze S; Ferrières J; Bruckert E; Van Ganse E; Chapman MJ; Liens D; Renaudin C
Int J Clin Pract; 2007 Nov; 61(11):1805-11. PubMed ID: 17850322
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk.
Brown BG; Zhao XQ
Am J Cardiol; 2008 Apr; 101(8A):58B-62B. PubMed ID: 18375243
[TBL] [Abstract][Full Text] [Related]
15. Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice.
Birjmohun RS; Hutten BA; Kastelein JJ; Stroes ES
Neth J Med; 2004; 62(7):229-34. PubMed ID: 15554597
[TBL] [Abstract][Full Text] [Related]
16. The potential role of HDL- and LDL-cholesterol modulation in atheromatous plaque development.
Chapman MJ
Curr Med Res Opin; 2005; 21 Suppl 6():S17-22. PubMed ID: 16138937
[TBL] [Abstract][Full Text] [Related]
17. What is the most effective strategy for managing diabetic dyslipidaemia?
Reasner CA
Atheroscler Suppl; 2005 Sep; 6(3):21-7. PubMed ID: 16054442
[TBL] [Abstract][Full Text] [Related]
18. Patients with low levels of high-density lipoprotein cholesterol: to treat or not to treat?
Tavintharan S; Lim SC; Sum CF
Singapore Med J; 2005 Oct; 46(10):519-28. PubMed ID: 16172771
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease.
Chapman MJ
Pharmacol Ther; 2006 Sep; 111(3):893-908. PubMed ID: 16574234
[TBL] [Abstract][Full Text] [Related]
20. Dyslipidaemia in diabetic patients: time for a rethink.
Shepherd J
Diabetes Obes Metab; 2007 Sep; 9(5):609-16. PubMed ID: 17697054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
